The importance of genetic polymorphisms in renal transplantation.
Genetic variations including single nucleotide polymorphisms, dinucleotide repeats and microsatellites have been identified in a number of genes encoding cytokines, cytokine receptors, chemokines and their receptors, adhesion molecules. Several of the polymorphisms are located in the promoter region of the gene, affect transcription or translation, and not infrequently determine the level of expression of the protein product. An interesting and testable hypothesis for the clinical heterogeneity and differential responsiveness in allograft recipients is genetic variation. These nucleotide sequence variations, polymorphisms located in genes contributing to immune repertory and in genes responsible for drug metabolism, are excellent candidates for the differential clinical phenotype.
Suthanthiran
M
M
Department of Transplantation Medicine, New York-Presbyterian Hospital, Weill Medical College of Cornell University, New York, USA. msuthan@med.cornell.edu
D016207:Cytokines / Q000235:genetics*; D005838:Genotype; D006084:Graft Rejection / Q000235:genetics* / Q000503:physiopathology; D006085:Graft Survival / Q000235:genetics; D006680:HLA Antigens / Q000502:physiology; D006801:Humans; D016753:Interleukin-10 / Q000235:genetics; D016030:Kidney Transplantation / Q000502:physiology*; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic / Q000502:physiology*; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
D016207:Cytokines; D006680:HLA Antigens; D014409:Tumor Necrosis Factor-alpha; D016753:Interleukin-10